US Patent Issued to Spitfire Pharma on March 25 for "Peptide pharmaceuticals for treatment of NASH and other disorders" (Texas Inventor)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,229, issued on March 25, was assigned to Spitfire Pharma LLC (Gaithersburg, Md.).

"Peptide pharmaceuticals for treatment of NASH and other disorders" was invented by John J Nestor (Sugar Land, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides peptide products comprising a peptide covalently attached to a surfactant moiety which have improved properties, including increased duration of action and bioavailability. The peptide products are useful for treating insulin resistance, diabetes, obesity, metabolic syndrome and cardiovascular diseases, and conditions associated therewith, such as NASH and PCOS."

The patent was file...